KDVD yields 0.76% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, KDVD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KDVD + JNJ for your $10,000?
KDVD seeks total returns by investing primarily in US small- and mid-cap companies that pay dividends or are expected to begin doing so. Investments span the entire dividend spectrum, including established high-yield businesses, steady dividend growers, and companies likely to initiate dividends, or initiate payouts or return cash through buybacks. The fund uses fundamental research supported by a deep team of sector analysts to identify stocks trading below their intrinsic value. It also evaluates factors such as earnings expectations, dividend sustainability, balance-sheet strength, management quality, and potential catalysts that could unlock additional value. The fund generally holds securities for more than a year but may sell positions when fundamentals deteriorate, the position becomes overweight, or more compelling opportunities emerge.
Full KDVD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.